Different holdings can hide the same risk

Follow the mechanism, not just the relationship

A direct exposure is usually straightforward to describe. A company buys a component from a supplier, earns revenue from a customer, or borrows from a lender. An indirect exposure follows another step: the supplier depends on a producer, the customer depends on financing, or the lender is exposed to a stressed borrower group.

The additional step can matter because disclosures are spread across different organizations. The original company may name its immediate supplier without identifying the supplier's critical input. A source about that input can be relevant to the original investment even when it never mentions the company you own.

However, each additional step also adds uncertainty. A relationship can be historical, immaterial, incorrectly resolved, or economically buffered. The right research process tests the chain rather than treating a discovered path as proof.

Work through a shared supplier scenario

Suppose two holdings use different distributors, but both distributors obtain a critical product from the same producer. A disruption at that producer might affect both holdings. The initial discovery is a shared dependency, not a forecast of lost earnings.

First establish that the relationships are current. Check whether the producer supplies the relevant product, whether the distributors serve the relevant business units, and whether the holdings still use those distributors. A company name appearing in an old presentation is weak evidence for current dependence.

Next test the economic exposure. Are there alternative sources? How much inventory is available? Can contracts delay or absorb higher costs? Could customers accept a substitute? A chain that looks fragile in a relationship map may prove resilient once these questions are answered.

Only then ask what the scenario could change: delivery timing, volumes, margins, working capital, or customer retention. State which effects are supported and which remain hypotheses. The path is useful because it directs the investigation, not because it settles the conclusion.

Look beyond supply chains

Shared dependencies can arise through customers, financing, geography, or regulation. A software provider and a service business may both depend on the same customer group's spending. Two different industries may rely on financing conditions that tighten together. A rule aimed at one activity may change the economics of several businesses that participate in it.

Those mechanisms deserve different evidence. A customer exposure calls for revenue concentration and demand analysis. A financing exposure calls for funding sources, maturities, and refinancing terms. A regulatory exposure calls for the actual rule, the affected activities, and the timing of implementation.

Avoid collapsing them into a generic claim that everything is connected. The point is to identify a particular dependency that could matter under a particular scenario, and to understand whether the portfolio already accounts for it.

A discovered relationship is not automatically a mispricing

A relationship you did not know about may be familiar to the market. Even when it is overlooked, its effect may be too small or too uncertain to matter. Discovery and valuation are separate tasks.

Before describing an opportunity, ask what expectations the current valuation appears to reflect, how the scenario differs from those expectations, and whether that difference is material. Ask what could prevent the mechanism from playing out and what evidence would disprove the view.

For risk research, the immediate action may be to monitor the dependency, investigate an offset, or revisit the size of a position. For opportunity research, it may be to study an alternative supplier or a company that benefits from the same change. Neither action follows automatically from the relationship alone.

Use a compact exposure review

Keep the review small enough to repeat when new evidence arrives. For each potentially important shared dependency, record:

• The holdings and the specific economic dependency they share.
• A source and date for every step in the relationship chain.
• The scenario that would activate the exposure.
• The likely business effect, its scale where known, and the uncertainties.
• The contracts, substitutes, hedges, or other buffers that could limit it.
• The next evidence to check and the portfolio decision it could inform.

The output should read as a research question with a documented mechanism. If the evidence cannot support the chain, preserve the question as unresolved rather than presenting it as an established exposure.

Keep the map tied to the investment

Clargus connects evidence across millions of documents to help investors investigate relationships around their companies and theses. The practical value is a more informed starting point: which dependency to examine, where the evidence sits, and what changed since the last review.

A portfolio can be diversified by label and concentrated by mechanism. Finding that mechanism is the beginning of the analysis. Establishing its materiality, testing the scenario, and deciding what to do remain the work that matters.